AVITA Medical (ASX: AVH) expects USD 14.3-15.3mn revenue in 2QFY24
AVITA Medical, Inc. (ASX: AVH)is a regenerative medicine firm, dedicated to transforming wound care and skin restoration through cutting-edge devices. The company's portfolio features the RECELL® System, FDA-approved for treating thermal burns, full-thickness skin defects, and repigmenting stable depigmented vitiligo lesions. Additionally, AVITA holds …
Team Kalkine |
17 Jul 2024| Read Time : 10 Mins